HEXVIX® Publications

Burger 2013

  Photodynamic diagnosis of non-muscle invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data Authors: Maximilian Burger, H Barton Grossman, Michael Droller, Joerg Schmidbauer, Gregers Hermann, Octavian Drăgoescu, Eleanor Ray, Yves Fradet, Alexander Karl, Juan Pablo Burgués, J Alfred Witjes, Arnulf Stenzl, Patrice Jichlinski, Dieter Jocham Journal: European […]


Stenzl 2010

  Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with non-muscle invasive bladder cancer Authors: A Stenzl, M Burger, Y Fradet, L A Mynderse, M S Soloway, J A Witjes, M Kriegmair, A Karl, Y Shen and H B Grossman  Journal: J Urol 2010; 184: 1907–1913 AIM To assess the impact of hexaminolevulinate (Hexvix®) blue-light […]


Hermann 2011

  Fluorescence guided trans-urethral resection of the bladder (TURBT) reduces bladder tumor recurrence due to less residual tumor tissue after TURBT in Ta/T1 patients: a randomized 2-center study Authors: G Hermann, K Mogensen, S Carlsson, N Marcussen, S Duun Citation: BJU International; Published online 17 Mars 2011 DOI: 10.1111/j.1464-410X.2011.10090.x Print Vol. 108, Issue 8b, p […]


Grossman 2012

  Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy Authors: H B Grossman, A Stenzl, Y Fradet, L A Mynderse, M Kriegmair, J A Witjes, M S Soloway, A Karl, M Burger Journal: J Urol 2012; 188: 58-62. Aim To assess the effect of early detection of papillary non-muscle invasive bladder cancer […]


Geavlete 2011

  Treatment changes and long-term recurrence rates after hexaminolevulinate (Hexvix®) fluorescence cystoscopy: does it really make a difference in patients with non-muscle invasive bladder cancer (NMIBC)? Authors: B Geavlete, R Multescu, D Georgescu, M Jecu, F Stanescu, P Geavlete Journal: BJU International; Published online 28 June 2011 DOI: 10.1111/j.1464-410X.2011.10374. Print; Vol. 109, Issue 4, p […]


Grossman 2007

  A phase III, multicenter comparison of Hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer Authors: H Barton Grossman, Leonard Gomella, Yves Fradet, Alvaro Morales, Joseph Presti, Chad Ritenour, Unyime Nseyo and Michael J Drollerıon on behalf of the PCB302/01 Study Group. Journal: Journal […]


Jocham 2005

  Improved detection and treatment of bladder cancer using Hexaminolevulinate imaging: A prospective, phase III multicenter study Authors: Dieter Jocham, Fred Witjes, Sigrid Wagner et al. Journal: Journal of Urology 2005; 174: 862-6. AIM To determine if improved tumor detection using Hexvix® blue-light cystoscopy could lead to improved treatment in patients with bladder cancer METHOD […]


Schmidbauer 2004

  Improved detection of urothelial carcinoma in situ with Hexaminolevulinate fluorescence cystoscopy Authors: Jörg Schmidbauer, Fred Witjes, Nikolaus Schmeller et al. Journal: Journal of Urology 2004; 171: 135-8. Aim To compare Hexvix® blue-light cystoscopy and standard white light cystoscopy for the detection of carcinoma in situ(CIS) in patients suspected of having high-risk bladder cancer. Methods […]